We’re excited to share that our Salem office will be undergoing construction starting on August 26, 2026, as we work to create a refreshed, updated, and more organized space for our patients.
BEYFORTUS (nirsevimab) is the recently approved antibody injection which has been shown to lessen the severity of disease due to Respiratory Syncytial Virus (RSV).